Synthesis and structure-activity relationships of pyridoxal-6-arylazo- 5'-phosphate and phosphonate derivatives as P2 receptor antagonists

Drug Development Research

Volumn 45, Issue 2, 1998, Pages 52-66

  Kim, Yong Chul ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

[4 FORMYL 3 HYDROXY 2 METHYL 6 (2 CHLORO 5 SULFONYLPHENYLAZO)PYRID 5 YL]METHYLPHOSPHONIC ACID; ION CHANNEL; PHOSPHONIC ACID DERIVATIVE; PURINE P2 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PYRIDOXAL DERIVATIVE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BLADDER; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ERYTHROCYTE; GUINEA PIG; HUMAN; HUMAN CELL; NONHUMAN; OOCYTE; RADIOASSAY; RECEPTOR BLOCKING; STRUCTURE ACTIVITY RELATION; TURKEY (BIRD); VAS DEFERENS; XENOPUS;

EID: 0032424086     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199810)45:2<52::AID-DDR2>3.0.CO;2-V     Document Type: Article

References (14)

1. Abbracchio MP, Burnstock G. 1994. Purinoceptors: are there families of P2x and P2y purinoceptors? Pharmacol Ther 64:445-475.
2. 2Y purinergic receptor agonists and guanine nucleotides. J Biol Chem 264:884-890.
3. Boyer JL, Zohn IE, Jacobson KA, Harden TK, 1994. Differential-effects of P2-purinoceptor antagonists on phospholipase C-coupled and adenylyl cyclase-coupled P2Y-purinoceptors. Br J Pharmacol 113:614-620.
4. 6-methyl 2′-deoxyadenosine 3′,5′-biphosphate. Brit J Pharmacol 124:1-3.
5. Brake AJ, Wagenbach MJ, Julius D, 1994. New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 371:519-523.
6. 2U- purinoceptors. Br J Pharmacol 116:2413-2416.
7. 1 receptor activation in HL-60 cells. Blood 87:2659-2664.
8. Bültmann R, Dudeck O, Starke K. 1996. Evaluation of P2-purinoceptor antagonists at two relaxation-mediating P2-purinoceptors in guinea-pig taenia coli. Naunyn Schmiedebergs Arch Pharmacol 353:445-451.
9. Burnstock G. 1993. Physiological and pathological roles of purines: an update. Drug Dev Res 28:195-206.
10. 2Y- subtypes. Drug Devel Res 31:206-219.
11. Burnstock G. 1996. P2 purinoceptors: historical-perspective and classification. Ciba Found Symp 198:1-34.
12. Burnstock G, King BF. 1996. Numbering of cloned P2 purinoceptors. Drug Dev Res 38:67-71.
13. Burnstock G, Wood JN. 1996. Purinergic receptors: their role in nociception and primary afferent neurotransmission. Curr Opin Neurobiol 6:526-532.
14. 1 receptors. J Med Chem 41:183-190.